Right Patient. Right Time. Right Line.
Vascular Access requires timely assessment, planning, insertion and follow-up. Appropriate device selection can impact the length of stay and complications, therefore, early assessment of a patient who requires a vascular access device should be considered upon admission.
The BioFlo Midline Catheter is an effective solution to preserving a patient's peripheral access. It provides a cost-effective alternative to multiple IV site rotations for patients who need short-term venous access. This improves the likelihood that the patient will receive his or her ordered therapy, which may lead to a shorter hospital stay, and improved patient satisfaction.
Proven to Reduce Thrombus Accumulation, In Vitro
The BioFlo Midline Catheter is the only midline catheter with Endexo Technology, providing a catheter material more resistant to platelet aggregation1. This novel, disruptive technology is present throughout the catheter shaft including the intraluminal, extraluminal and cut surface of the catheter, and is present for the life of the catheter.
BioFlo Midline Catheter
- X-ray confirmation is not required after placement
- Visibly marked as a midline catheter to aid in identification
- Multiple kit configurations to meet clinician needs:
Maximal Barrier Nursing Kit MST Kit Catheter Only Kit Available with standard stylet or nitinol guidewires only
- Power Injectable
Important Risk Information
BIOFLO MIDLINE WITH ENDEXO TECHNOLOGY
INTENDED USE/ INDICATIONS FOR USE: The BioFlo Midline is indicated for short term access (< 30 days) to the peripheral venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and the sampling of blood and blood products.
Maximum Power Injection Flow Rate
3F Single Lumen/20 cm—2 mL/sec
4F Single Lumen/20 cm—6 mL/sec
5F Single Lumen/20 cm—6 mL/sec
5F Dual Lumen/20 cm—6 mL/sec
CONTRAINDICATIONS: Venous thrombosis in any portion of the vein to be catheterized; Conditions that impede venous return from the extremity such as paralysis or lymphedema after mastectomy; Orthopedic or neurological conditions affecting the extremity; Anticipation or presence of dialysis grafts or other intraluminal devices, including pacemakers; Hypercoagulopathy unless considerations are made to place the patient on anticoagulation therapy; Pre-existing skin surface or subsurface infection at or near the proposed catheter insertion site; Anatomical distortion of the veins from surgery, injury or trauma; Inadequate antecubital veins; Anatomical irregularities (structural or vascular) which may compromise catheter insertion or catheter care procedures.
WARNINGS: Refer to procedural steps for additional warnings. Due to the risk of exposure to blood borne pathogens, care providers must adhere to guidelines for universal blood and body fluid precautions in the care of all patients. Sterile technique must be strictly adhered to during any handling of the device. Do not use if package is opened or damaged. If using bacteriostatic saline, do not exceed 30 mL in a 24-hour period. Do not fully insert catheter up to suture wing. Do not use the catheter with chemicals that are incompatible with any of its accessories, as catheter damage may occur. Do not re-sheath any needles. Place needles in puncture resistant, leak proof, sharps containers per institutional protocol. Do not attempt to trim the catheter with the guidewire or stylet loaded as catheter, stylet, or guidewire may become damaged resuling in patient injury. Failure to warm contrast media to body temperature prior to power injection may result in catheter failure. Failure to ensure patency of the catheter prior to power injection studies may result in catheter failure. Power injector's pressure limiting (safety cut-off) feature may not prevent over-pressurization of occluded catheter. Exceeding the maximum allowable flow rate (Table 2) may result in catheter failure and/or catheter tip displacement. Catheter indication for power injection of contrast media implies the catheter’s ability to withstand this procedure, but does not imply appropriateness of this procedure for a particular patient. A trained clinician is responsible for evaluating the health status of a patient as it pertains to a power injection procedure. The maximum pressure of power injectors used with the power injectable BioFlo Midline must not exceed 325 psi (2,240 kPa). Prior to loading stylet or guidewire cut catheter to desired length. Do not cut catheter while stylet or guidewire is loaded into catheter as device damage or patient injury may occur. Therapies NOT appropriate for BioFlo Midline catheters include those therapies requiring central venous access. Refer to standards of practice and institutional policies.
POTENTIAL COMPLICATIONS / ADVERSE EVENTS: Air embolism, bleeding, brachial plexus or other nerve injury, catheter dislodgement, catheter embolism, catheter erosion through skin/vessel, catheter fragmentation, catheter malfunction, catheter malposition, catheter migration, catheter occlusion, catheter retraction, catheter rupture, death, drug or contrast medium precipitate, extravasation/infiltration of infusate, embolism, endocarditis, exit site necrosis, fibrin sheath formation, foreign body rejection, hematoma, hemorrhage, hemothorax, infection, inflammation/phlebitis, intolerance reaction to contrast media, intolerance reaction to implanted device, malposition, nerve damage, pain, pleural effusion, pneumothorax, pulmonary embolism, renal compromise, sensitivity or allergy, sepsis, subintimal venous or myocardial injection, thoracic duct injury, thromboembolism, thrombophlebitis, vascular thrombosis, vessel damage, vessel stenosis, vessel tamponade.
Refer to Directions for Use provided with the product for complete instructions, warnings, and precautions.
CAUTION: Federal Law (USA) restricts this device to sale by or on the order of a physician.
Consult your AngioDynamics representative for country-specific product availability.